Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Motor Activity 20Polycystic Ovary Syndrome 10Prostatic Neoplasms 7Breast Neoplasms 6Neoplasms 5Colorectal Neoplasms 4Insulin Resistance 3Lung Neoplasms 2Fatigue 2Esophageal Neoplasms 2Cardiotoxicity 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Primary Dysautonomias 1Pediatric Brain Tumor 1Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, Follicular 1Lupus Erythematosus, Systemic 1Inflammation 1Hodgkin Disease 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Disease 1Diabetes Mellitus, Type 1 1Chemotherapy-Related Cognitive Impairment 1Cardiovascular Diseases 1

Interventions

Carboplatin 156Paclitaxel 154Bevacizumab 96Cyclophosphamide 61Gemcitabine 46olaparib 45Cisplatin 45Topotecan 44niraparib 40liposomal doxorubicin 40pembrolizumab 38Surveys and Questionnaires 33Filgrastim 31Hyperthermic Intraperitoneal Chemotherapy 29Docetaxel 27Taxes 25Blood Specimen Collection 24fludarabine 23Drug Therapy 23Cytoreduction Surgical Procedures 23Peripheral Blood Stem Cell Transplantation 21Etoposide 21Doxorubicin 21Magnetic Resonance Spectroscopy 20durvalumab 17Specimen Handling 17Albumin-Bound Paclitaxel 17Immunoglobulin G 15Disulfides 15Letrozole 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ovarian Neoplasms × High-Intensity Interval Training × Clear all
NCT05029154 2025-06-12

Exercise Preconditioning in Ovarian Cancer

University of Virginia

Phase NA Terminated
8 enrolled
Gynecologic

Ovarian Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡